Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of FOF1-ATP synthase

In addition to playing a central role in the mitochondria as the main producer of ATP, FOF1-ATP synthase performs diverse key regulatory functions in the cell membrane. Its malfunction has been linked to a growing number of human diseases, including hypertension, atherosclerosis, cancer, and some ne...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luis Fernando Cofas-Vargas, Paola Mendoza-Espinosa, Luis Pablo Avila-Barrientos, Diego Prada-Gracia, Héctor Riveros-Rosas, Enrique García-Hernández
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-10-01
coleção:	Frontiers in Pharmacology
Assuntos:	FOF1-ATP synthase inhibition conformational dynamics solvent sites binding free energy hot spot binding residues bacterial pathogens
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1012008/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!